Models | Change in cSBP, mmHg (95% CI) | P value | Â | Change in cSBP, mmHg (95% CI) | P value |
---|---|---|---|---|---|
Model I†| |||||
RLP-C, mmol/L | Â | Â | LDL-C, mmol/L | Â | Â |
 Q1: < 0.39 | Ref. |  | Q1: < 2.73 | Ref. |  |
 Q2: 0.39–< 0.54 | 1.43 (0.10–2.77) | 0.035 | Q2: 2.73–< 3.24 | 0.97 (−0.33–2.27) | 0.143 |
 Q3: 0.54–< 0.73 | 1.89 (0.48–3.31) | 0.009 | Q3: 3.24–< 3.78 | 0.43 (−0.92–1.79) | 0.529 |
 Q4: ≥0.73 | 4.57 (3.08–6.06) | < 0.001 | Q4: ≥3.78 | 0.93 (−0.50–2.37) | 0.202 |
Model II†| |||||
RLP-C, mmol/L | Â | Â | TC, mmol/L | Â | Â |
 Q1: < 0.39 | Ref. |  | Q1: < 4.70 | Ref. |  |
 Q2: 0.39–< 0.54 | 1.47 (0.15–2.78) | 0.029 | Q2: 4.70–< 5.28 | 0.14 (−1.16–1.44) | 0.832 |
 Q3: 0.54–< 0.73 | 1.90 (0.51–3.29) | 0.007 | Q3: 5.28–< 5.95 | 0.92 (−0.42–2.26) | 0.178 |
 Q4: ≥0.73 | 4.50 (2.98–6.02) | < 0.001 | Q4: ≥5.95 | 0.66 (−0.80–2.12) | 0.374 |
Model III†| |||||
RLP-C, mmol/L | Â | Â | TG, mmol/L | Â | Â |
 Q1: < 0.39 | Ref. |  | Q1: < 0.87 | Ref. |  |
 Q2: 0.39–< 0.54 | 1.22 (−0.17–2.62) | 0.087 | Q2: 0.87–< 1.24 | 0.96 (−0.41–2.32) | 0.170 |
 Q3: 0.54–< 0.73 | 1.53 (−0.07–3.13) | 0.061 | Q3: 1.24–< 1.79 | 1.02 (−0.57–2.61) | 0.209 |
 Q4: ≥0.73 | 3.91 (1.92–5.89) | < 0.001 | Q4: ≥1.79 | 1.47 (−0.50–3.43) | 0.144 |
Model IV†| |||||
RLP-C, mmol/L | Â | Â | HDL-C, mmol/L | Â | Â |
 Q1: < 0.39 | Ref. |  | Q1: < 1.19 | Ref. |  |
 Q2: 0.39–< 0.54 | 1.72 (0.40–3.03) | 0.010 | Q2: 1.19–< 1.42 | 0.09 (−1.24–1.42) | 0.895 |
 Q3: 0.54–< 0.73 | 2.36 (0.99–3.73) | < 0.001 | Q3: 1.42–< 1.68 | 0.52 (−0.90–1.94) | 0.474 |
 Q4: ≥0.73 | 5.15 (3.67–6.63) | < 0.001 | Q4: ≥1.68 | 0.59 (−0.97–2.15) | 0.457 |
Model V†| |||||
RLP-C, mmol/L | Â | Â | Non-HDL-C, mmol/L | Â | Â |
 Q1: < 0.39 | Ref. |  | Q1: < 3.22 | Ref. |  |
 Q2: 0.39–< 0.54 | 1.15 (−0.23–2.53) | 0.104 | Q2: 3.22–< 3.83 | 1.67 (0.31–3.03) | 0.016 |
 Q3: 0.54–< 0.73 | 1.54 (−0.00–3.08) | 0.050 | Q3: 3.83–< 4.49 | 0.79 (−0.70–2.28) | 0.300 |
 Q4: ≥0.73 | 4.10 (2.36–5.84) | < 0.001 | Q4: ≥4.49 | 1.52 (−0.16–3.20) | 0.077 |